# The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma

> **NCT03143140** · NA · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 120 (actual)

## Conditions studied

- Liver Neoplasms

## Interventions

- **OTHER:** PAFA
- **OTHER:** tumor ablation

## Key facts

- **NCT ID:** NCT03143140
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05-22
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-12-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143140, "The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03143140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*